Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy
2016 · Blood · 737 citations
https://doi.org/10.1182/blood-2015-08-665547
M
Min Fang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
323
Papers
7.8K
Citations
42
h-index
125
i10-index
Min Fang is an academic researcher from UMass Memorial Health Care. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Acute Lymphoblastic Leukemia research & Cancer Genomics and Diagnostics. The author has an h-index of 42, co-authored 275 publications.
ORCID: 0000-0001-6688-437XPapers by this author
worksSignificance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission
2013 · Blood · 350 citations
https://doi.org/10.1182/blood-2013-06-506725
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
2014 · Blood · 72 citations
https://doi.org/10.1182/blood-2013-12-544957
Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome
2016 · Biology of Blood and Marrow Transplantation · 47 citations
https://doi.org/10.1016/j.bbmt.2016.03.029
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report
2020 · Biomarker Research · 35 citations
https://doi.org/10.1186/s40364-020-00208-1
Coherent pipeline for biomarker discovery using mass spectrometry and bioinformatics
2010 · BMC Bioinformatics · 15 citations
https://doi.org/10.1186/1471-2105-11-437
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat